Vimarsana
Biggest News Aggregation in the World

Page 7 - Peter Altman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Peter Altman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Peter Altman Today - Breaking & Trending Today

BioCardia, Inc. (NASDAQ:BCDA) Q4 2022 Earnings Call Transcript - Vimarsana News

BioCardia, Inc. (NASDAQ:BCDA) Q4 2022 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for standing by. Good afternoon, and welcome to the BioCardia 2022 Yearend Conference Call. At this time, all participants are in a listen-only mode.

Positive Echocardiography Data from BioCardia Phase III CardiAMP Cell Therapy Heart Failure Trial Presented at American College of Cardiology Annual Meeting - Vimarsana News

Positive Echocardiography Data from BioCardia Phase III CardiAMP Cell Therapy Heart Failure Trial Presented at American College of Cardiology Annual Meeting

Results Suggest CardiAMP Cell Therapy May Have Ability to Restore and Maintain Heart Function to Previously Non-Functioning Areas of the Heart Up to Two Years After Treatment

Volunteers needed as Chasco Fiesta gears up for the 101 year - Vimarsana News

Volunteers needed as Chasco Fiesta gears up for the 101 year

The Chasco Fiesta’s original goal back in 1922 was to attract people to what was then a young city and raise money for the community library.

BioCardia Announces FDA Approval of IND Application for Allogeneic NK1R+ Human Mesenchymal Stem Cells for Ischemic Heart Failure - Vimarsana News

BioCardia Announces FDA Approval of IND Application for Allogeneic NK1R+ Human Mesenchymal Stem Cells for Ischemic Heart Failure

Approval marks second clinical trial approved by FDA this year for Company’s NK1R+ MSC platform

BioCardia, Inc. (BCDA) Q3 2022 Earnings Call Transcript - Vimarsana News

BioCardia, Inc. (BCDA) Q3 2022 Earnings Call Transcript

BioCardia, Inc. (NASDAQ:NASDAQ:BCDA) Q3 2022 Earnings Conference Call November 09, 2022, 16:30 ET Company Participants Jules Abraham - CORE IR Peter Altman - President & CEO David...